Cargando…
CFC1 is a cancer stemness-regulating factor in neuroblastoma
BACKGROUND: Despite the use of aggressive therapy, survival rates among high-risk neuroblastoma (NB) patients remain poor. Cancer stem cells (CSCs) are considered to be critically involved in the recurrence and metastasis of NB and are isolated as NB spheres. METHODS: The gene expression profiling o...
Autores principales: | Chikaraishi, Koji, Takenobu, Hisanori, Sugino, Ryuichi P., Mukae, Kyosuke, Akter, Jesmin, Haruta, Masayuki, Kurosumi, Masafumi, Endo, Takaho A., Koseki, Haruhiko, Shimojo, Naoki, Ohira, Miki, Kamijo, Takehiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542166/ https://www.ncbi.nlm.nih.gov/pubmed/28620148 http://dx.doi.org/10.18632/oncotarget.18464 |
Ejemplares similares
-
Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
por: Akter, Jesmin, et al.
Publicado: (2021) -
EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications
por: Li, Zhenghao, et al.
Publicado: (2018) -
ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
por: Parvin, Sultana, et al.
Publicado: (2023) -
Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
por: Shinno, Yoshitaka, et al.
Publicado: (2022) -
Comparative epigenomics by machine learning approach for neuroblastoma
por: Sugino, Ryuichi P., et al.
Publicado: (2022)